Outcomes of hepatitis C‐ and hepatitis B core antibody‐positive grafts in orthotopic liver transplantation

Sammy Saab, Albert J. Chang, Scott Comulada, Sunil K. Geevarghese, R. Dean M. Anselmo, Francisco Durazo, Steven Han, Douglas G. Farmer, Hasan Yersiz, Leonard I. Goldstein, R. Mark Ghobrial, Ronald W. Busuttil – 30 December 2003 – The use of hepatitis B core antibody (HBcAb)‐ and hepatitis C virus antibody (HCV+) liver grafts for transplantation in selected populations has not affected patient and graft survival. We reexamined the clinical outcomes of using these HBcAb+ and HCV+ grafts at our institution, in addition to studying recipients of combined HBcAb+/HCV+ grafts.

Preoperative liver donor evaluation: Imaging and pitfalls

Koenraad J. Mortelé, Vito Cantisani, Roberto Troisi, Bernard de Hemptinne, Stuart G. Silverman – 30 December 2003 – This article discusses the rationale behind living (related) donor liver transplantation, the role of imaging in the preoperative evaluation of the potential donor, and the currently available imaging modalities for fulfilling this task. Furthermore, the normal hepatic vascular and biliary anatomy, as seen on imaging, is reviewed and the most common anomalies are highlighted.

The small remnant liver after major liver resection: How common and how relevant?

Cengizhan Yigitler, Olivier Farges, Reza Kianmanesh, Jean‐Marc Regimbeau, Eddie K. Abdalla, Jacques Belghiti – 30 December 2003 – The maximum extent of hepatic resection compatible with a safe postoperative outcome is unknown. The study goal was to determine the incidence and impact of a small remnant liver volume after major liver resection in patients with normal liver parenchyma.

A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation

Antonino Cavallari, Umberto Cillo, Bruno Nardo, Franco Filipponi, Enrico Gringeri, Roberto Montalti, Fabio Vistoli, Francesco D'Amico, Antonio Faenza, Franco Mosca, Alessandro Vitale, Davide D'Amico – 30 December 2003 – Primary dysfunction (PDF) still occurs after orthotopic liver transplantation (OLT). Celsior solution (CS) might offer some advantages over the conventional University of Wisconsin (UW) solution for organ preservation, but to date, this has not been prospectively evaluated in the context of OLT.

Acute Budd‐Chiari syndrome during pregnancy: Surgical treatment and orthotopic liver transplantation with successful completion of the pregnancy

Wendy J. Grant, Timothy McCashland, Jean F. Botha, Byers W. Shaw, Debra L. Sudan, Alejandro Mejia, Kishore Iyer, Alan N. Langnas – 30 December 2003 – A 26‐year‐old woman presented with acute Budd‐Chiari syndrome 18 weeks into a pregnancy. She was found to be heterozygous for the G20210A prothrombin gene mutation. She was treated with portacaval shunt placement and successfully completed the pregnancy, with a healthy baby delivered at 31 weeks' gestation.

Incidence and prevalence of coccidioidomycosis in patients with end‐stage liver disease

Janis E. Blair, Vijayan Balan, David D. Douglas, Joseph G. Hentz – 30 December 2003 – Coccidioidomycosis is an endemic fungal infection of the desert southwestern United States. Patients with end‐stage liver disease (ESLD) have not been described as having a high rate of coccidioidal infection. We prospectively evaluated 290 patients with ESLD for liver transplantation and found that 6 of these patients )2.1%) had active coccidioidal infection at presentation.

Acquired hemophilia A after liver transplantation: A case report

Garrett M. Hisatake, Teng‐Wei Chen, John F. Renz, Douglas G. Farmer, R. Mark Ghobrial, Hasan Yersiz, Rafael G. Amado, Leonard Goldstein, Ronald W. Busuttil – 30 December 2003 – It is well recognized that orthotopic liver transplantation rapidly corrects the coagulation disorder observed in patients with hemophilia A or B combined with end‐stage liver disease; however, the transmission of hemophilia from a donor to a transplant recipient has not been reported previously.

Subscribe to